Home Mundo Anthropic to float on the stock market today as it raises $81bn...

Anthropic to float on the stock market today as it raises $81bn in record IPO – business live

83
0

Anthropic’s shares expected to pop when trading begins

There's just 90 minutes to go until the US stock market opens for trading.

Despite lifting the price of its IPO yesterday, to $83 a share, Anthropic is still expected to jump in value once its stock starts trading.

That means we should see the traditional ‘pop' when a new company joins the stock market, and investors who missed out on the sale process try to buy in.

Chris Beauchamp, chief market analyst at investing and trading platform IG, has the details:

double quotation mark“IG's pre-IPO market for Anthropic has seen a notable bounce since Nvidia's results as sentiment towards tech and AI becomes more enthusiastic as the Jensen scandal settles down.

From a low of $97 earlier in the week IG clients expect the stock to easily top $100 in initial trading and continue to gain. With the price now trading at $105, the AI giant would be valued at $1.9 trillion, just shy of the magic $2 trillion mark that had initially been mooted when the IPO plans first became widespread news.

Markets needed reassurance that the AI trade still has plenty of life left in it, and it looks like the Anthropic IPO will do just that.â€

Reminder: Anthropic's float is going to be the biggest IPO of all time, as it will rake in $83.1bn through its share sale, giving a valuation of $1.5tn.

Such was the demand for shares that investors at Hargreaves Lansdown only received a third of their order.

And as flagged earlier, its shares were up 20% in ‘grey market' trading this morning.

Anthropic to float on the stock market today as it raises bn in record IPO – business live
A screen shows a live broadcast outside the NASDAQ Market site on the day Anthropic, PBC (ANT) holds their initial public offering (IPO), in New York City Photograph: Mike Segar/Reuters

Key events

Anthropic shares indicated to open at $104

New York's market makers are still trying to set an opening price for Anthropic.

The very latest word is that Anthropic shares are indicated to open at $104, Reuters reports.

That would be a 25% jump compared to the $83 at which shares were sold in its IPO….

Anthropic chief executive Dario Amodei also argued that today's IPO will give it more power to act responsibly.

Speaking at the Nasdaq, he said:

double quotation mark“Today puts the company in a stronger financial position, and in doing so, only strengthens our resolve to do the right thing.â€

Anthropic itself raised nearly $79.4bn from shares sold in the IPO, while its co-founders sold almost $2bn worth between them.

While today's IPO turns Anthropic's cofounders into billionaires, the protest against the AI industry continues outside the Nasdaq:

People protest outside the NASDAQ MarketSite, on the day Anthropic, PBC (ANT) holds their initial public offering (IPO), in New York City, US, November 19, 2026. REUTERS/Mike Segar
People protest outside the NASDAQ MarketSite, on the day Anthropic holds their initial public offering, in New York City, US. Photograph: Mike Segar/Reuters

Anthropic share expected to pop by 20%

The chatter from the New York trading floor is that Anthropic's shares are going to open around 20% above their IPO price.

According to Bloomberg, Anthropic shares are indicated to open at $100 each.

That would be a sharp bounce compared to the IPO price of $83 a share, which has raised $81.3bn from investors.

Dario Amodei: AI has real risks, but they’re avoidable

Shortly before ringing the Nasdaq opening bell, Anthropic CEO Dario Amodei issued a warning about the dangers of AI.

He said:

double quotation markWe've always been honest that this techology has very real risks.

These range from misuse of the technology by individuals or nation states, to economic disruption, to losing control of AI systems.

Amodei say these risks are not inevitable; they can be avoided, explaining:

double quotation markAvoiding them depends on the choices made by the people making AI.

There is a gigantic difference between how AI will go if we pay little attention to safety, versus how it will go if we are obsessed with safety.

He then insists that an obsession with safety and public benefit has been “build into Anthropic's DNA from the startâ€.

[Reminder, Amodie and his cofounders set up Anthropic after leaving rival OpenAI, after disagreements over AI safety issues].

Nasdaq jumps

Now, we wait for Anthropic's shares to start trading.

Having raised their IPO price to $83 a share last night, will the stock jump higher when trading begins?

The tech-focused Nasdaq index has made a strong start – it's up 1.7%, or 420 points, to 24,850 points.

Photo: Anthropic ring the opening bell

Members of the board of Anthropic at the Nasdaq MarketSite for the start of trading
Members of the board of Anthropic at the Nasdaq MarketSite for the start of trading Photograph: Charly Triballeau/AFP/Getty Images

Anthropic ring the opening bell

The biggest IPO in world history is officially underway!

After a clock counted down to 9.30am in New York, Anthropic rang the opening bell, and the AI titan's top staff are applauding happily at Nasdaq Marketsite.

A group of Anthropic staff have now gathered at the Nasdaq Marketsite, ready to mark the start of trading.

Several of the co-founders are there, including both Amodei siblings, and Jack Clark.

CEO of Anthropic Dario Amodei and President and co-founder of Anthropic Daniela Amodei
CEO of Anthropic Dario Amodei and President and co-founder of Anthropic Daniela Amodei Photograph: Brendan McDermid/Reuters

Now Dario Amodei takes the stage, saying he and his cofounders started Anthropic beause “we believe the most powerful technology of our time should be built for the benefit of humankindâ€.

He explains that he and his sister Daniela lost their father to a disease that became curable just a few years later.

Dario Amodei argues that AI can cut through the complexity that scientists face when trying to cure diseases, and bring new treatments faster.